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Abstract
Purpose Colonic diverticular bleeding is a major cause of
lower gastrointestinal bleeding. However, a limited number
of studies have been reported on the risk factors for diver-
ticular bleeding. Our aim was to identify risk factors for
diverticular bleeding.
Methods Our study design is a case (diverticular bleeding)–
control (diverticulosis) study. We prospectively collected
information of habits, comorbidities, history of medications
and symptoms by a questionnaire, and diagnosed diverticular
bleeding and diverticulosis by colonoscopy. Logistic regres-
sion models were used to estimate odds ratio (OR) and 95%
confidence interval (CI).
Results A total of 254 patients (diverticular bleeding, 45;
diverculosis, 209) were selected for analysis. Cluster (≥10
diverticula) type (OR, 4.0; 95% CI, 1.8–8.9), hypertension
(OR, 2.2; 95% CI, 1.0–4.6), ischemic heart disease (OR, 2.4;
95% CI, 1.1–5.4), and chronic renal failure (OR, 6.4; 95% CI,
1.3–32) were independent risk factors for diverticular bleeding.
Conclusions Large number of diverticula, hypertension, and
concomitant arteriosclerotic diseases including ischemic
heart disease and chronic renal failure are risk factors for
diverticular bleeding. This study identifies new information
on the risk factors for diverticular bleeding.
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Introduction
Colonic diverticula are pseudodiverticula resulting from her-
niation of the mucosa and submucosa through a weakened
portion of the colonic wall [1]. Colonic diverticulosis is an
acquired disease caused by increased intestinal pressure due to
decreased intake of dietary fiber and mucosal fragility associ-
ated with aging [2–5]. The typical locations of colonic diver-
ticula differ between the Western and Asian populations,
appearing predominantly left-sided in the Western countries
and predominately right-sided in Asia [6]. With changes in
dietary habits and the aging of society, the incidence of colonic
diverticulosis is expected to increase [3, 4].
Although colonic diverticulosis is usually asymptomatic,
diverticulitis and diverticular bleeding can occasionally occur.
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In particular, colonic diverticular bleeding causes sudden,
painless hematochezia, and with massive bleeding, becomes
a condition with high morbidity and mortality rates, in
which blood transfusion and urgent treatment are required
[7]. Bleeding develops in 3–5% of patients with colonic
diverticulosis, and surgical intervention is required in 10–
30% of the cases [8, 9]. In addition, patients with colonic
diverticular bleeding show a high rate of recurrence within
a short period [10]. With the increase in colonic diverticu-
losis, an increase in diverticular bleeding is to be expected
[11]. However, the pathogenesis of bleeding remains un-
clear [12, 13]. Hypertension and use of nonsteroidal anti-
inflammatory drugs (NSAIDs) have been reported as risk
factors [12–14], but these issues have yet to be extensively
investigated.
Accurate accumulation of data is important to evaluate
the risk factors. Previous reports have investigated medical
records retrospectively and thus may have been influenced
by recall bias. We prospectively evaluated data including
comorbidities, medications, and locations of diverticula.




We prospectively collected information of habits, comorbid-
ities, history of medications, type of diverticula, and symp-
toms. We performed a case (diverticular bleeding)–control
(diverticulosis) study to identify the risk factors for colonic
diverticular bleeding.
Patient selection
Eligibility criteria included patients who underwent colono-
scopy at the National Center for Global Health and Medi-
cine (NCGM) between November 2009 and February 2011.
NCGM is a tertiary care academic center with 900 beds,
located in metropolitan Tokyo. Exclusion criteria were as
follows: patients who did not provide informed consent,
patients who did not know what medications they were
receiving, patients with whom communication was difficult,
patients who could not understand written documents,
patients who were unable to write, patients with impaired
vision, patients with decreased activities of daily living,
patients who were unable to respond to the questionnaire
due to serious illness, patients without diverticula in the
colon on colonoscopy, patients in whom total colonoscopy
could not be performed, and patients with lower gastroin-
testinal (GI) bleeding due to causes other than colonic
diverticular bleeding (Fig. 1).
Diagnosis
An electronic video endoscope (high-resolution scope, mod-
el CFH260; Olympus Optical, Tokyo, Japan) was used for
the diagnosis of colonic diverticulosis and colonic divertic-
ular bleeding (Fig. 2). Intestinal lavage for endoscopic ex-
amination was performed using 2 L of solution containing
polyethylene glycol. Diagnosis of colonic diverticular
Fig. 1 Patient selection
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bleeding was based on the criteria reported by Jensen [15],
including a chief complaint of painless hematochezia and
the exclusion of hemorrhoidal bleeding on anal examina-
tion. We assessed the location and type of diverticula using
colonoscopy. Location was defined as right-sided, involving
the transverse or proximal colon; left-sided, involving the
descending or distal colon; or bilateral, around the entire
colon. Type was defined as sporadic type for 1 diverticulum,
scatter type for 2–9 diverticula, and cluster type for ≥10
diverticula.
Questionnaire
The questionnaire included lifestyle habits, comorbid dis-
eases, medications, and symptoms. Medical history was
obtained in a face-to-face interview with medical staff. For
the medication history, prescriptions and medical records were
reviewed in addition to information from the patients them-
selves, in order to avoid omissions.
Habits
Smoking and alcohol drinking habits were inquired
about. A smoker was defined as someone who smoked
at the time of, or anytime prior to, the interview. A drinker
was defined as someone who consumed alcohol at least
1 day/week.
Comorbidities
Comorbidities that were evaluated included hypertension,
diabetes mellitus, hyperlipidemia, ischemic heart disease,
chronic liver dysfunction, and chronic renal failure. Hyper-
tension was considered present in patients taking any anti-
hypertensive drugs. Diabetes mellitus was defined based on
the diagnostic criteria of the American Diabetes Association
[16]. Hyperlipidemia was considered present in patients
taking any antihyperlipidemic drugs. Ischemic heart disease
was considered present in any patient with a history of
myocardial infarction or angina pectoris. Chronic liver dys-
function included chronic viral hepatitis and alcoholic liver
disease. Chronic renal failure was considered present in
patients on hemodialysis or peritoneal dialysis, or with
serum creatinine ≥2.0 mg/dL.
History of medications
Patients were asked about the use of antiplatelet drugs
(aspirin, clopidogrel, cilostazol, ticlopidine), anticoagulants,
acetaminophen, NSAIDs, steroids, and antihypertensive
drugs. The survey form included photographs of all these
oral drugs, which are approved in Japan. Use of a medication
was defined as oral administration starting at least 1 month
before the interview.
Symptoms of constipation
Symptoms of constipation were evaluated in 7 grades using
the subscale of Gastrointestinal Symptom Rating Scale [25]:
1, no impediment to daily activities; and 7, symptoms so
severe as to be intolerable. Positive symptoms were defined
as a score ≥3.
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Table 2 Univariate analysis:
risk factors for colonic
diverticular bleeding
Factor Cases (n045) Controls (n0209) Odds ratio 95% CI p value
Age
<65 13 87 1 (referent)
≥65 32 122 1.8 0.84–3.9 0.11
Gender
Female 12 64 1 (referent)
Male 33 145 1.2 0.57–2.8 0.60
Location of diverticuluma
Left side 8 51 1 (referent)
Right side 13 112 1.4 0.53–3.5
Bilateral 24 46 4.5 2.1–9.6 <0.01
Type of diverticulumb
Sporadic/scatter type 10 125 1 (referent)
Cluster type 35 83 5.3 2.4–13 <0.01
Habits
Alcohol drinking
No 27 96 1 (referent)
Yes 18 113 0.57 0.28–1.1 0.09
Smoking
No 22 101 1 (referent)
Yes 23 108 1.0 0.49–2.0 0.95
Comorbidities
Hypertension
No 13 119 1 (referent)
Yes 32 90 3.3 1.5–7.1 <0.01
Hyperlipidemia
No 34 175 1 (referent)
Yes 11 33 1.7 0.71–3.9 0.17
Diabetes mellitus
No 39 172 1 (referent)
Yes 6 37 0.72 0.23–1.9 0.48
Ischemic heart disease
No 28 182 1 (referent)
Yes 17 27 4.1 1.8–8.9 <0.01
Chronic liver dysfunction
No 43 195 1 (referent)
Yes 2 14 0.65 0.069–3.0 0.75
Chronic renal failure
No 39 206 1 (referent)
Yes 6 3 11.0 2.1–67 <0.01
Medication
Antiplatelet drugsc
No 26 159 1 (referent)






No 42 195 1 (referent)
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Ethics
The study protocol was approved by the NCGM Ethics
Committee. Written informed consent was obtained from
all patients prior to starting the study. The study protocol
was registered with UMIN 000004533.
Statistics
Patients with colonic diverticular bleeding were defined as
cases, patients with colonic diverticulosis were defined as
controls, and the relationships with clinical findings were
examined. To determine the risk factors for colonic diver-
ticular bleeding, we estimated the odds ratio (OR) and 95%
confidence interval (CI). Age was compared between
groups using the Mann–Whitney U test, while frequency
distributions were compared using the chi-square test or
Fisher’s exact test. In multivariate analysis, we used a multiple
logistic regression model with factors that had p values <0.2
on univariate analysis. A value of p<0.05 was considered
statistically significant. All statistical analyses were performed
using Stata version 10 software (StataCorp, College Station,
TX, USA).
Results
During the study period, 3,722 patients underwent colono-
scopy (Fig. 1). Of these, 903 patients participated in medical
interviews (Fig. 1). Of the 903 patients, 645 patients had no
colonic diverticula. Ultimately, 254 patients were included for
analysis, comprising 45 patients with colonic diverticular
bleeding and 209 patients with colonic diverticulosis. Table 1
shows the patient characteristics. Many of the patients were
elderly men. Diverticulum location was predominantly right-
sided or bilateral. Diverticulum type was cluster type in about
half of the cases.
Bilateral diverticula (OR, 4.5; 95% CI, 2.1–9.6), cluster
type (OR, 5.3; 95% CI, 2.4–13), hypertension (OR, 3.3;
95% CI, 1.5–7.1), ischemic heart disease (OR, 4.1; 95%
CI, 1.8–8.9), chronic renal failure (OR, 11; 95% CI, 2.1–67),
antiplatelet drugs (OR, 2.3; 95% CI, 1.1–4.8), and NSAIDs
(OR, 2.7; 95% CI, 1.0–6.8) were significant risk factors for
diverticular bleeding (Table 2). On multivariate analysis, clus-
ter type (OR, 4.0; 95% CI, 1.8–8.9; p<0.01), hyperten-
sion (OR, 2.2; 95% CI, 1.0–4.6; p00.05), ischemic heart
disease (OR, 2.4; 95% CI, 1.1–5.4; p00.03), and chronic
renal failure (OR, 6.4; 95% CI, 1.3–32; p00.02) were
identified as independent risk factors for diverticular
bleeding (Table 3).
Discussion
The present detailed prospective survey identified cluster-
type diverticula, hypertension, ischemic heart disease, and
Table 2 (continued)
Factor Cases (n045) Controls (n0209) Odds ratio 95% CI p value
Yes 3 14 0.99 0.18–3.8 1.0
Acetaminophen
No 45 205 1 (referent)
Yes 0 4 0 0–4.5 1.0
NSAIDs
No 36 191 1 (referent)
Yes 9 18 2.7 1.0–6.8 0.02
Steroids
No 44 201 1 (referent)
Yes 1 8 0.57 0.013–4.5 1.0
Symptom
Constipation
No 32 164 1 (referent)
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Table 3 Multivariate analysis: risk factors for colonic diverticular
bleeding
Odds ratio 95% CI p value
Cluster type 4.0 1.8–8.9 <0.01
Hypertension 2.2 1.0–4.6 0.05
Ischemic heart disease 2.4 1.1–5.4 0.03
Chronic renal failure 6.4 1.3–32 0.02
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chronic renal failure as risk factors for colonic diverticular
bleeding. Typical diverticular locations differ between the
Asian and Western populations [6]. In our study, diverticula
were predominantly right-sided or bilateral, unlike the pre-
dominantly left-sided distribution seen in the Western
countries. Bilateral [13] and left-sided [14] predominance
have not been reported as risk factors for diverticular bleed-
ing, and location was not found to be a significant risk factor
for diverticular bleeding with predominantly right-sided
bleeding in this study. On the other hand, the number of
diverticula has not previously been noted as a risk factor, but
as the number of diverticula increased, the risk of bleeding
increased significantly in our study. This represents a new
finding. We speculate that diverticular bleeding occurs due
to rupture of exposed blood vessels inside the diverticulum.
As the number of diverticula increases, the number of poten-
tially exposed blood vessels may also increase, resulting in a
greater likelihood of bleeding.
Under conditions of hypertension, increased pressure
within exposed blood vessels may elevate the risk for bleed-
ing [12]. Vascular endothelial injury and atheroma forma-
tion occur, leading to arteriosclerosis. This arteriosclerosis
causes fragility of exposed blood vessels in the diverticula,
which then may lead to bleeding.
In our study, ischemic heart disease was newly identified
as a risk factor for diverticular bleeding. Ischemic heart
disease is a condition that reflects arteriosclerosis [24].
A case report found that patients with chronic renal
failure may develop diverticular bleeding [17]. Our case–
control study is the first to identify chronic renal failure as a
risk factor for diverticular bleeding. In chronic renal failure,
blood vessels throughout the body, including the intestine,
are affected by arteriosclerosis [18–20]. In addition, heparin,
which is used in dialysis, and platelet function also influence
bleeding. Renal failure in association with arteriosclerosis
and a bleeding tendency would thus represent a risk factor
for diverticular bleeding. Patients with hemodialysis and
chronic renal failure are at an increased risk for bleeding,
and in such patients, caution should be exercised.
As with hypertension, ischemic heart disease, and chron-
ic renal failure, rupture of exposed blood vessels in diver-
ticula may occur due to arteriosclerosis. Use of antiplatelet
drugs has often been reported as a risk factor for lower GI
bleeding [21]. However, in reports on diverticulosis and
diverticular bleeding, as in the present study, antiplatelet
drugs have not been identified as an independent risk factor
on multivariate analysis [12, 13]. Antiplatelet drugs, includ-
ing aspirin, often are reported to cause mucosal injury of the
upper GI tract and the small intestine [22, 23], but to the best
of our knowledge, mucosal injury, such as ulcer formation
in the colon, has not been reported. These drugs may thus
also have few effects on blood vessels within diverticula.
The influence of antiplatelet drugs on colonic diverticulosis
should further be investigated in studies with a suitable
sample size and study design.
By inhibiting PG synthesis through blocking of
cyclooxygenase-1 activity, NSAIDs decrease mucosal pro-
tective function. NSAID injury of the lower GI tract mucosa
has often been reported [21], and NSAIDs are also thought
to be a risk factor in colonic diverticular bleeding [12, 14].
However, NSAIDs were not a risk factor for bleeding in our
study. This may be because we excluded patients with
decreased daily activities, due to low back pain or arthritic
pain, and patients who were unable to undergo colonoscopy.
Analysis therefore could not be performed in patients taking
large doses of NSAIDs over a long period for chronic low
back pain, which may have led to some bias. To investigate
whether NSAIDs represent a risk factor for diverticular
bleeding, a study that includes patients with decreased
activities of daily living should be conducted.
No studies on the relationship between constipation and
diverticular bleeding have previously been reported. As
constipation is a condition that causes increased intestinal
pressure [6], we hypothesized it as a potential risk factor. In
our study, constipation was not identified as a risk factor for
bleeding. This also represents a new finding. Hard stools
alone, with constipation, may not have influence on mucosal
injury within diverticula.
Although endoscopic therapy, angiography, and surgery
were performed for colonic diverticular bleeding, it was not
an established standard therapy to prevent bleeding [7].
Recently, a case report of barium enema therapy [26] and
a case series of endoscopic band ligation therapy [27] were
reported to effectively prevent colonic diverticular bleeding.
Hypertension and chronic renal failure, which we deter-
mined as risk factors in this study, were also risk factors
for rebleeding [10]. Therefore, our findings helped in the
selection of high-risk patients who required these novel
therapies in order to prevent bleeding. However, a limited
number of studies on therapies for rebleeding have been
reported. The effect of these therapies on colonic diverticu-
lar bleeding should be further investigated.
The limitation of this study was that patients in poor
general health, for whom obtaining a medical history or
performing colonoscopy was difficult, were not included.
This may have introduced selection bias. To generalize the
results of our study, a future multicenter cohort study would
be desirable.
Hypertension, ischemic heart disease, and chronic renal
failure are common diseases in daily clinical practice. In
patients with colonic diverticulosis, the presence of these
comorbidities must be considered in the risk for bleeding.
Colonic diverticulosis is primarily a disease of the elderly
and is a common disease encountered not only by gastro-
enterologists but also by physicians in general clinical prac-
tice (including cardiologists and nephrologists). Our results
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thus provide useful information for general medical care
settings. Cluster-type diverticula, hypertension, ischemic
heart disease, and chronic renal failure represent indepen-
dent risk factors for colonic diverticular bleeding. This study
identified new risk factors for colonic diverticular bleeding.
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